Cellebrite Rg-A
CLBT
USD
STOCK MARKET:
NMS
Closed
 
...
Large gap with delayed quotes
Last quote
02/28/2026 - 02:00:00
Bid
02/27/2026 - 21:59:59
Bid
Volume
Ask
02/27/2026 - 21:59:59
Ask
Volume
13.34
-0.42 ( -3.05% )
13.33
8,800
13.34
1,700
More information
Analysis by TheScreener
24.02.2026
Evaluation Slightly negative  
Interest Strong  
Sensibility High  
Analysis date: 24.02.2026
Global Evaluation
  Slightly negative
The stock is classified in the slightly negative zone since 02.12.2025.
Interest
  Strong
Three stars since 20.02.2026.
Earnings Rev Trend
  0.10
 
Compared to seven weeks ago, the analysts have not significantly revised their earnings per share estimates (changes between +1% and -1% are considered neutral). But the last significant trend is positive since 16.01.2026 at a price of 17.00.
Evaluation
  Overvalued
 
Based on its growth potential and our own criteria, we believe the share price is currently moderately overvalued.
MT Tech Trend
  Negative
 
The stock appears oversold from a technical perspective due to its recent losses. It trades below its forty day technical trend since 02.01.2026.
4wk Rel Perf
  -23.09%
 
The stock appears oversold from a technical perspective, with a four week dividend-adjusted underperformance of of 23.09% behind the Tel Aviv 125 Index.
Sensibility
  High
The stock has been on the high-sensitivity level since 25.02.2025.
Bear Market Factor
  Low
On average, the stock has a tendency to minimize the drops in the index by -0.07%.
Bad News Factor
  Low
When the stock's pressure is specific, the market sanction on average is 4.47%.
Mkt Cap in $bn
  3.02
With a market capitalization between $2 & $8bn, CELLEBRITE DI is considered a mid-cap stock.
G/PE Ratio
  0.77
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.9 indicates that investors must pay a premium for the estimated growth potential: premium.
LT P/E
  30.83
The estimated PE is for the year 2027.
LT Growth
  23.79%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
  6
Over the last seven weeks, an average of 6 analysts provided earnings per share estimates.
Dividend Yield
  0.00%
The company is not paying a dividend.
Beta
  39
For 1% of index variation, the stock varies on average by 0.39%.
Correlation
  0.20
Stock movements are strongly independent of index variations.
Value at Risk
  3.03
The value at risk is estimated at USD 3.03. The risk is therefore 24.01%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
  25.02.2025